2021 Roche Cancer Diagnostics Market Shares and Competitive Position by Product and Country - Performance, Capabilities, Goals and Strategies

December 2020 | - | ID: 27FCF92B004EEN
Venture Planning Group

Abstracts

This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes cancer diagnostics sales and market share estimates by product and country for Roche and its main competitors, as well as a profile of the company's diagnostics business.The report is available by section, and can be customized to specific information needs and budget.

Contents

Roche France Total Tumor Marker Sales by Major Supplier
Roche France AFP Testing Market Diagnostics Sales by Major Supplier
Roche France CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Roche France CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Roche France CA 125 Testing Market Diagnostics Sales by Major Supplier
Roche France CEA Testing Market Diagnostics Sales by Major Supplier
Roche France NSE Testing Market Diagnostics Sales by Major Supplier
Roche France PAP Testing Market Diagnostics Sales by Major Supplier
Roche France PSA Testing Market Diagnostics Sales by Major Supplier
Roche Germany Total Tumor Marker Sales by Major Supplier
Roche Germany AFP Testing Market Diagnostics Sales by Major Supplier
Roche Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Roche Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Roche Germany CA 125 Testing Market Diagnostics Sales by Major Supplier
Roche Germany CEA Testing Market Diagnostics Sales by Major Supplier
Roche Germany PSA Testing Market Diagnostics Sales by Major Supplier
Roche Italy Total Tumor Markers Sales by Major Supplier
Roche Italy AFP Testing Market Diagnostics Sales by Major Supplier
Roche Italy CEA Testing Market Diagnostics Sales by Major Supplier
Roche Italy PSA Testing Market Diagnostics Sales by Major Supplier
Roche Japan Total Tumor Marker Sales by Major Supplier
Roche Japan AFP Testing Market Diagnostics Sales by Major Supplier
Roche Japan PAP Testing Market Diagnostics Sales by Major Supplier
Roche Japan PSA Testing Market Diagnostics Sales by Major Supplier
Roche Spain Total Tumor Marker Sales by Major Supplier
Roche Spain AFP Testing Market Diagnostics Sales by Major Supplier
Roche Spain CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Roche Spain 19-9 Testing Market Diagnostics Sales by Major Supplier
Roche Spain CA 125 Testing Market Diagnostics Sales by Major Supplier
Roche Spain CEA Testing Market Diagnostics Sales by Major Supplier
Roche Spain PSA Testing Market Diagnostics Sales by Major Supplier
Roche UK Total Tumor Marker Sales by Major Supplier
Roche UK CEA Testing Market Diagnostics Sales by Major Supplier
Roche UK PSA Testing Market Diagnostics Sales by Major Supplier
Roche US Total Cancer Diagnostic Testing Market by Major Supplier
Roche US AFP Testing Market Diagnostics Sales by Major Supplier
Roche US CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Roche US CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Roche US CA 125 Testing Market Diagnostics Sales by Major Supplier
Roche US CEA Testing Market Diagnostics Sales by Major Supplier
Roche US Ferritin Testing Market Diagnostics Sales by Major Supplier
Roche US HCG Testing Market Diagnostics Sales by Major Supplier
Roche US Insulin Testing Market Diagnostics Sales by Major Supplier
Roche US Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
Roche US Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
Roche US PSA Testing Market Diagnostics Sales by Major Supplier